Assignee
NOVMETAPHARMA CO LTD
KR·14 granted patents·17 pending applications·18 citations·filing 2017–2024
Top patents by PatentIndex Score
31 records- 0193US11433114B2Composition for cell protection containing cyclo histidine-proline as active ingredientNOVMETAPHARMA CO LTD·Filed 2021·Granted Sep 6, 2022·3 cites·18 claims
- 0287US10792280B2Pharmaceutical composition comprising amodiaquine and anti-diabetes drug as effective ingredient for prevention or treatment of diabetesNOVMETAPHARMA CO LTD·Filed 2017·Granted Oct 6, 2020·5 cites·8 claims
- 0386US10683300B2Polymorphic forms of Cyclo (-His-Pro)NOVMETAPHARMA CO LTD·Filed 2019·Granted Jun 16, 2020·5 cites·28 claims
- 0480US11820834B2Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney diseaseNOVMETAPHARMA CO LTD·Filed 2020·Granted Nov 21, 2023·1 cites·15 claims
- 0577US11975041B2Composition comprising CHP (cyclo-his pro) for preventing, improving or treating of bone loss related diseaseNOVMETAPHARMA CO LTD·Filed 2018·Granted May 7, 2024·1 cites·13 claims
- 0676US11607441B2Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredientsNOVMETAPHARMA CO LTD·Filed 2018·Granted Mar 21, 2023·1 cites·6 claims
- 0776US10918693B2Composition for cell protection containing cyclo histidine-proline as active ingredientNOVMETAPHARMA CO LTD·Filed 2017·Granted Feb 16, 2021·2 cites·13 claims
- 0875US12534496B2Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney diseaseNOVMETAPHARMA CO LTD·Filed 2023·Granted Jan 27, 2026·0 cites·18 claims
- 0975US11890317B2Cell-protecting composition containing cyclo histidine-proline as active ingredientNOVMETAPHARMA CO LTD·Filed 2022·Granted Feb 6, 2024·0 cites·14 claims
- 1070US2024082240A1Method for treatment of cytokine release syndromeNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1167US2025161301A1Composition for preventing, ameliorating or treating obesity and diabetes comprising zinc gluconate and cyclo-hispro as active ingredientsNOVMETAPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 1265US11850246B2Method for treatment of cytokine release syndromeNOVMETAPHARMA CO LTD·Filed 2021·Granted Dec 26, 2023·0 cites·9 claims
- 1364US2026061001A1Use of composition containing zinc salt and cyclo-hispro for prevention, alleviation or treatment of respiratory diseaseNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1462US2024140955A1Peg-modified cyclic dipeptidesNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1560US2023390279A1Composition and method for treating cancerNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1659US2026027083A1Use of ppar agonist for improvement of energy metabolismNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1758US12496309B2Method for treatment of pancreatitisNOVMETAPHARMA CO LTD·Filed 2022·Granted Dec 16, 2025·0 cites·8 claims
- 1858US11547737B2Compositions and methods for treating virus infectionNOVMETAPHARMA CO LTD·Filed 2021·Granted Jan 10, 2023·0 cites·20 claims
- 1957US2024197816A1Composition and method for prolong survival of transplant and recipientNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2057US2022218793A1Use of composition for preventing, ameliorating, or treating bone loss disorders, comprising cyclo-hispro (chp) and parathyroid hormoneNOVMETAPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2156US12558396B2Use of cyclo(His-Pro) (CHP) for preventing, alleviating or treating peritoneal fibrosisNOVMETAPHARMA CO LTD·Filed 2020·Granted Feb 24, 2026·0 cites·8 claims
- 2256US2024261366A1Treatment of beta-cell failure or dysfunctionNOVMETAPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 2355US2024317700A1Process for preparing gossypetinNOVMETAPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2454US2022054541A1Method for treating inflammatory bowel diseasesNOVMETAPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 2553US2025011267A1Process for preparing aryl ethene compoundNOVMETAPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2652US11413270B2Method for the treatment of pancreatitisNOVMETAPHARMA CO LTD·Filed 2020·Granted Aug 16, 2022·0 cites·7 claims
- 2750US2023165855A1Use of cyclo-hispro (chp) for lowering blood pressureNOVMETAPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 2849US2020345728A1Compositions and methods for treatment of atherosclerosisNOVMETAPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2948US2023017330A1USE OF COMPOSITION FOR ENHANCING ANTICANCER EFFECT, COMPRISING ERRy INHIBITOR AS ACTIVE INGREDIENTNOVMETAPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3044US2021401880A1Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active IngredientNOVMETAPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 3142US2021100872A1Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes MellitusNOVMETAPHARMA CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOVMETAPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →